In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): A fluoroquinolone used for treatment and control of colibacillosis in poultry

Diagnostic Microbiology and Infectious Disease

Volumn 32, Issue 1, 1998, Pages 55-64

  Jones, Ronald N ^a   Erwin, Meridith E ^a   Washington, J A ^b   Murray, P R ^c   Walker, R ^d   Knapp, C ^e   Haugen, T ^f  

^a UNIVERSITY OF IOWA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e AccuMed/Sensititre   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN; NORDIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POULTRY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; VETERINARY MEDICINE;

ANIMALS; ANTI-INFECTIVE AGENTS; CHICKENS; CIPROFLOXACIN; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; HUMANS; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; POULTRY DISEASES; QUALITY CONTROL;

EID: 0032409888     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00063-7     Document Type: Article

References (16)

1. Barry AL, Fuchs PC, Jones RN, the Collaborative Antimicrobial Susceptibility Testing Group (1989) Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Diagn Microbiol Infect Dis 12:413-420.
2. Barry AL, Thornsberry C, Jones RN (1986) In vitro evaluation of A-55619 and A-56620: Two new quinolones. Antimicrob Agents Chemother 29:40-43.
3. Cormican MG, Erwin ME, Jones RN (1997) Avoparcin, a glycopeptide used in animal foods: Antimicrobial spectrum and potency tested against human isolates from the United States. Diagn Microbiol Infect Dis 29:241-248.
4. Donnelly JP, Voss A, Witte W, Murray BE (1996) Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans? J Antimicrob Chemother 37:388-390.
5. Fernandes PB, Hanson CW, Stamm JM, Vojtko C, Shipkowitz NL, St. Martin E (1987) The frequency of in vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivo. J Antimicrob Chemother 19:449-465.
6. Fernandas PB, Shipkowitz N, Bowr RR, Jarvis KP, Weisg J, Chu DTW (1986) In vitro and in vivo potency of five new fluoroquinolones against anaerobic bacteria. J Antimicrob Chemother 18:693-701.
7. Gavan TL, Jones RN, Barry AI, Fuchs PC, Gerlach EH, Matsen JM, Reller LB, Thornsberry C, Thrupp LD (1981) Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: A collaborative study. J Clin Microbiol 14:67-72.
8. Hayes PW, Gustafson RH, Lotgering FK, Mudd AJ (1996) Response. J Antimicrob Chemother 37:390-392.
9. Jordens JZ, Bates J, Griffiths DT (1994) Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 34:515-528.
10. Marshall SA, Jones RN, Wanger A, Washington JA, Doern GV, Leber AL, Haugen TH (1996) Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: Ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin. J Clin Microbiol 34:2027-2029.
11. National Committee for Clinical Laboratory Standards (NCCLS) (1994a) Development of in Vitro Susceptibility Testing Criteria and Quality Control Parameters: Approved Guideline M23-A. Wayne, Pa.: NCCLS.
12. National Committee for Clinical Laboratory Standards (NCCLS) (1994b) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Proposed Standard M31-P. Wayne, Pa.: NC-CLS.
13. National Committee for Clinical Laboratory Standards (NCCLS) (1997a) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 4th Ed.: Approved Standard M7-A4. Wayne, Pa.: NCCLS.
14. National Committee for Clinical Laboratory Standards (NCCLS) (1997b) Performance Standards for Antimicrobial Disk Susceptibility Tests, 6th Ed.: Approved Standard M2-A6. Wayne, Pa.: NCCLS.
15. National Committee for Clinical Laboratory Standards (NCCLS) (1998) Performance Standards for Antimicrobial Susceptibility Testing: Supplemental Tables M100-S8. Wayne, Pa.: NCCLS.
16. Piddock LJ (1996) Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy? J Antimicrob Chemother 38:1-3.